Tag: Samsung Biologics
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Samsung Biologics to manufacture Moderna’s COVID-19 vaccine in South Korea
Global biotechnology company Moderna has inked a manufacturing services and supply agreement with Samsung Biologics under which the South Korea-based contract development and manufacturing...
Featured Article
Smarter energy decisions: GridBeyond unveils AI-powered Bid Optimiser in Australia
As Australia’s energy transition accelerates, businesses participating in the National Electricity Market (NEM) are facing growing challenges in managing their energy assets efficiently.
